news
Novel siRNA therapeutic could lower cardiovascular disease risk
A Phase II trial for the small interfering RNA (siRNA) therapeutic lepodisiran is currently underway, assessing its ability to reduce lipoprotein(a) levels.
List view / Grid view
Cleveland Clinic
news
Could novel gene therapy treat sickle cell disease?
Researchers have revealed positive preliminary data from a CRISPR gene therapy trial for sickle cell disease.
news
Absorbable antibiotic envelope cuts cardiac infections
An absorbable antibiotic envelope could cut the number of cardiac infections after surgery to implant or replace cardioverter defibrillators and pacemakers...
news
Rivaroxaban reduced blood clots and related death in cancer patients
Through a clinical trial, Cleveland researchers have identified how rivaroxaban reduces blood clots in cancer patients and also decreases related deaths...
